Prevention and treatment of breast cancer by suppressing aromatase activity and expression

Annals of the New York Academy of Sciences

Volumn 963, Issue , 2002, Pages 229-238

  Chen, Shiuan ^a   Zhou, Dujin ^a   Okubo, Tomoharu ^a   Kao, Yeh Chih ^a   Eng, Elizabeth T ^a   Grube, Baiba ^a   Kwon, Annette ^a   Yang, Chun ^a   Yu, Bin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aromatase; Breast cancer; Enzyme; Estrogen; Promoter; Transcript

Indexed keywords

ANASTROZOLE; ANTIESTROGEN; AROMATASE; AROMATASE INHIBITOR; ESTROGEN; FLAVONE; ISOFLAVONE; LETROZOLE; LIGNAN; PHYTOESTROGEN; PLANT EXTRACT; REGULATOR PROTEIN; TAMOXIFEN; VOROZOLE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER PREVENTION; CANCER THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DIETARY INTAKE; DRUG MECHANISM; ENZYME INHIBITION; GENE ACTIVITY; GENE CONTROL; GRAPE; GRAPE JUICE; HUMAN; MUSHROOM; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

BASIDIOMYCOTA; GASTROPODA; VITACEAE; VITIS SP.;

EID: 0036293455     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04115.x     Document Type: Conference Paper

References (51)

1. Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies
2. The importance of local synthesis of estrogen within the breast
3. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR)
4. Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinico-pathologic correlation
5. Stromal spindle cells contain aromatase in human breast tumors
6. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers
7. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients
8. Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture
9. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene
10. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities
11. Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells
12. Hormonal approaches to breast cancer treatment and prevention: An overview
13. Aromatase inhibitors and breast cancer
14. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
15. Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors
16. Mechanisms of tamoxifen resistance
17. Acquired tamoxifen resistance: Correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hyroxytamoxifen
18. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens
19. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration
20. Treatment of advanced postmenopausal breast cancer with aromatase inhibitor, 4-hydroxyandrostenedione: Phase 2 report
21. Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma: Correlation of clinical and hormonal responses
22. Arimidex (ZD1033): A selective, potent inhibitor of aromatase in postmenopausal female volunteers
23. National Surgical Adjuvant Breast and Bowel Project Investigators: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
24. The potential of aromatase inhibitors in breast cancer prevention
25. New non-steroidal aromatase inhibitors: Focus on R76713
26. Neoadjuvant endocrine therapy
27. Vegetables, fruit and phytoestrogens as preventive agents
28. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer
29. Breast cancer: Magnitude of the problem and descriptive epidemiology
30. Dietary effects on breast-cancer risk in Singapore
31. Soy isoflavonoids and cancer prevention
32. Estrogens, phytoestrogens, and breast cancer
33. Inhibition of human aromatase by mammalian lignans and isolavonoid phytoestrogens
34. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes
35. Aromatase inhibition by flavonoids
36. Inhibition of estrogen synthetase (aromatase) by flavones
37. Effects of flavonoids on aromatase activity: An in vitro study
38. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
39. Binding characteristics of aromatase inhibitors and pytoestrogens to human aromatase
40. Molecular basis of the inhibition of human aromatase by flavone and isoflavone phytoestrogens. A site-directed mutagenesis study
41. Suppression of breast cancer cell growth with grape juice
42. Regulation of aromatase expression in human ovarian surface epithelial cells
43. Human aromatase: cDNA cloning. Southern blot analysis, and assignment of the gene to chromosome 15
44. Endocrine disorders associated with inappropriately high aromatase expression
45. Identification of a promoter and a silencer at the 3′-end of the first intron of the human aromatase gene
46. Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells
47. Characterization of a silencer element in the human aromatase gene
48. Identification and characterization of a cAMP-responsive element in the region upstream from promoter I.3 of the human aromatase gene
49. Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor
50. Down-regulation of promoter I.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH)